Initial Public Offering - The company completed its Initial Public Offering on October 1, 2025, raising gross proceeds of $460,000,000 from the sale of 46,000,000 Units at $10.00 per Unit, including an over-allotment option of 6,000,000 Units [103]. - A total of $460,000,000 from the Initial Public Offering was placed in a Trust Account, which will be invested in U.S. government treasury obligations with a maturity of 185 days or less [105]. - The company incurred transaction costs of $23,835,700, which included $7,000,000 in cash underwriting fees and $16,100,000 in deferred underwriting fees [104]. Financial Performance - As of September 30, 2025, the company reported a net loss of $20,600 for the three months ended and a total net loss of $71,168 since inception [111]. - The company held cash of $2,000,000 and a working capital deficit of $7,654,068 as of September 30, 2025 [112]. - The company has not generated any operating revenues to date and does not expect to do so until after completing its initial business combination [110]. Use of Funds - The company intends to use funds held outside the Trust Account primarily for identifying and evaluating target businesses and related due diligence [116]. Debt and Obligations - The company has no long-term debt or significant contractual obligations other than a monthly payment of $20,000 to the Sponsor for administrative services [120]. - The company may need to obtain additional financing to complete its business combination or to cover redemptions of public shares [118]. - The company has not engaged in any off-balance sheet arrangements as of September 30, 2025 [119].

Financial Performance - Q3 2025 total revenue reached $9.9 million, reflecting a 13% year-over-year increase, and year-to-date revenue of $29.7 million, up 28%[12] - Mainframe Studios revenue surged 45% year-over-year and 65% year-to-date, driven by contracts with major clients like Sony, Disney, and SpinMaster[12] - The company reported a 10% improvement in loss from operations over the second quarter and a 32% improvement year-to-date compared to the prior year[12] - Kartoon Studios maintains a strong balance sheet with $27.1 million in current assets and $24.0 million in stockholders' equity at quarter-end[12] Subscriber Growth and Engagement - Kartoon Channel! achieved its strongest month ever in October 2025, with record highs in subscriber growth and total watch time[13] Financing and Investment - The company completed a $7.3 million financing with an institutional investor in October 2025, with potential to raise an additional $7.3 million through warrants[13] Production and Contracts - Multi-year production contracts extend through 2027, ensuring reliable revenue visibility[19] - The upcoming release of Hundred Acre Wood's Winnie & Friends is set for a Christmas Eve 2025 preview, with a full premiere in 2026[20] Licensing and Partnerships - The Stan Lee Universe continues to expand through licensing partnerships, leveraging a fan base of over 30 million worldwide[20] Innovation and Development - The company is actively developing its A.I. animation unit, which is expected to transform production capabilities and industry standards[6]

Financial Performance - Q3 2025 total revenue reached $9.9 million, reflecting a 13% year-over-year increase, and year-to-date revenue of $29.7 million, up 28%[12] - Mainframe Studios revenue surged 45% year-over-year and 65% year-to-date, driven by contracts with major clients like Sony, Disney, and SpinMaster[12] - The company reported a 10% improvement in loss from operations over Q2 and a 32% improvement year-to-date compared to the previous year[12] - Kartoon Studios maintains a strong balance sheet with $27.1 million in current assets and $24.0 million in stockholders' equity at quarter-end[12] Subscriber Growth and Engagement - Kartoon Channel! achieved its strongest month ever in October 2025, with record highs in subscriber growth and total watch time[13] Financing and Contracts - The company secured $7.3 million in financing from an institutional investor, with potential for an additional $7.3 million through warrants[13] - Multi-year production contracts extend through 2027, ensuring reliable revenue streams[19] Upcoming Releases and Expansions - The upcoming release of Hundred Acre Wood's Winnie & Friends is set for a Christmas Eve 2025 preview, with a full premiere in 2026[20] - The Stan Lee Universe is expanding through licensing and collectibles partnerships, leveraging a fan base of over 30 million worldwide[20] Innovation and Development - The company is actively developing its A.I. animation unit, which is expected to transform production capabilities and industry standards[6]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the transition period from ____________ to ____________ Commission File Number: 001-40775 (Mark One) ALPHA MODUS HOLDINGS, INC. ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) For the quarterly period ended September 30, 2025 (State or other jurisdiction of incorporation or organization) ☐ TRANSITION REPORT PURSUANT TO SECTION ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or organization) Delaware 86-3386030 (I.R.S. Employer Identification No.) 20311 Chartwell Center Dr., #1469 Cornelius, NC 28031 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transi ...

Sales Performance - The Company reported a decrease in sales for EWCP products due to decreased customer orders, while TPA products saw an increase in customer orders [78]. - Three customers accounted for 65% of product sales during the three months ended September 30, 2025, compared to 60% in the same period of 2024 [81]. Financial Performance - Gross profit as a percentage of sales decreased by 20% due to increased costs associated with scaling up new products [78]. - Cash provided by operating activities for the nine months ended September 30, 2025, was $6,757,198, down from $7,787,989 in 2024 [84]. - Working capital as of September 30, 2025, was $21,780,752, a decrease from $22,714,190 as of December 31, 2024 [84]. - Interest income increased due to rising interest rates [79]. Future Outlook - The Company anticipates no significant capital requirements for the twelve months ending September 30, 2026 [85]. - The Company has sufficient cash resources to meet future commitments and cash flow requirements for the coming year [84]. Research and Development - Research and development expenses increased due to successful project completions in 2025 [80]. One-time Events - The Company experienced a one-time loss on the sale of 30.1% of a Florida-based LLC in 2024 [79].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40386 ONEMEDNET CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 86-2076743 (State or other juris ...

Satellite Launch and Technology - Sidus Space successfully launched three hybrid, additively manufactured LizzieSat® satellites equipped with advanced AI edge-computing capabilities in just over 12 months[117]. - The LizzieSat platform includes upgrades such as an AI processor capable of handling 248 trillion operations per second (TOPS) and a payload processor with speeds up to 12 Gb/s[120]. - The modular LizzieSat platform can be customized for various technologies and mission requirements, supporting a broad range of operational and data collection needs[119]. - Successfully launched LizzieSat®-1 in March 2024, LizzieSat®-2 in December 2024, and completed the build and launch of LizzieSat®-3 in Q1 2025, establishing a micro-constellation for near real-time solutions[141]. - Integrated second-generation automated identification system (AIS) technology into the LizzieSat® satellite constellation, enhancing vessel tracking and monitoring solutions[149]. - Expected to launch four to six more LizzieSat® satellites ranging from 100kg to 400kg over the next 24 months, expanding commercial satellite operations[151]. Contracts and Revenue - Signed a preliminary contract valued at $120 million to design and build the first-generation lunar fleet of Data Storage Spacecraft for Lonestar Data Holdings, reinforcing the adaptability of the LizzieSat® platform[141]. - Awarded a $2 million contract from Craig Technologies to manufacture two fleet interactive display equipment (FIDE) pre-production unit main panels for U.S. Navy Propulsion systems[141]. - The data-as-a-service model is subscription-based with multiple price tiers, applicable to government, defense, and commercial customers[123]. - Revenue for the three months ended September 30, 2025, decreased by $570,900, a 31% decline compared to the same period in 2024[177]. - Non-related party revenue fell approximately 68% to about $559,000 for the three months ended September 30, 2025, down from approximately $1.8 million in the same period of 2024[178]. - Related party revenue increased by 562% to approximately $739,000 for the three months ended September 30, 2025, compared to approximately $112,000 in the same period of 2024[178]. Financial Performance - Gross profit decreased 450% for the nine months ended September 30, 2025, resulting in a loss of approximately $3.9 million compared to a loss of approximately $719,000 for the same period in 2024[187]. - Net loss for the nine months ended September 30, 2025, was approximately $18.1 million, an increase of 52% compared to a net loss of approximately $11.8 million in 2024[194]. - Current assets decreased by approximately $1.1 million to approximately $21.1 million as of September 30, 2025, from approximately $22.2 million as of December 31, 2024[200]. - Current liabilities increased by approximately $1.1 million to $15.4 million as of September 30, 2025, primarily due to an increase in asset-based loan liability[201]. - Adjusted EBITDA for the nine months ended September 30, 2025, was approximately $(12.6) million, a decrease of 51% compared to $(8.3) million in 2024[194]. - Cash used in operating activities was approximately $14.1 million, an increase of 37% compared to $10.3 million in the same period of 2024[203]. Manufacturing and Operations - The company operates a 35,000-square-foot manufacturing facility that is ISO 9001:2015 and AS9100 Rev. D certified, supporting the manufacturing, testing, and assembly of space-grade hardware[124]. - Sidus Space's manufacturing capabilities include precision machining, multi-material 3D printing, and a reconfigurable avionics lab for producing space system components[124][130]. - The company aims to expand its space and defense hardware operations from one shift to two and a half shifts, targeting growth in avionics and wire harness divisions[153]. - Established a fully operational mission control center to manage satellite operations and enhance constellation operation capabilities[141]. Market Trends and Growth - The global space economy is projected to reach $1.8 trillion by 2035, growing from $630 billion in 2023, with an average annual growth rate of 9%[167]. - The small satellite market is expected to grow at a CAGR of 16.4%, reaching approximately $30.6 billion by 2034, driven by cost-effectiveness and advances in miniaturization[168]. - The small satellite launch market is projected to grow from $7.6 billion to $28.4 billion, reflecting a 279% increase[172]. - The company is actively expanding its international market presence, signing partnership agreements with companies in Germany, Japan, Bahrain, and India[163]. Intellectual Property and Innovation - Strengthened intellectual property portfolio with the approval of new patents and the publication of a patent application protecting enhanced functionality of the LizzieSat® Modular Satellite Platform System[142]. - The company holds 14 granted patents and 13 pending applications related to space technologies, indicating a strong focus on innovation[157]. Financial Adjustments and Reporting - The company adopted ASC 606 for revenue recognition, which did not have a material impact on the consolidated financial statements[211]. - The company accounts for most fixed price or time and materials contracts as performance obligations satisfied over time, reflecting the right to collect based on services provided[216]. - The provision for expected credit losses on trade receivables is estimated based on historical information and customer solvency, with adjustments for forward-looking information[218]. - The company is evaluating the benefits of relying on exemptions and reduced reporting requirements provided by the JOBS Act as an "emerging growth company"[226].

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40386 ONEMEDNET CORPORATION (Exact name of Registrant as specified in its Charter) Delaware 86-2076743 (State or other juris ...

Mergers and Acquisitions - As of September 30, 2025, NanoVibronix, Inc. completed a merger with ENvue Medical Holdings, resulting in the formation of two wholly-owned subsidiaries: NanoVibronix Ltd. and ENvue Medical Holdings LLC[179]. Financial Performance - For the three months ended September 30, 2025, revenues were approximately $722 thousand, an increase of 92% compared to $376 thousand in the same period of 2024[212]. - Gross profit for the three months ended September 30, 2025, was approximately $189 thousand, a 42% increase from $133 thousand in 2024[214]. - For the nine months ended September 30, 2025, revenues were approximately $2,241 thousand, a 6% increase from $2,114 thousand in 2024[225]. Expenses - Research and development expenses decreased by approximately 11% to $221 thousand for the three months ended September 30, 2025, compared to $249 thousand in 2024[216]. - Selling and marketing expenses surged by approximately 349% to $812 thousand for the three months ended September 30, 2025, from $181 thousand in 2024[218]. - General and administrative expenses increased by approximately 108% to $1,403 thousand for the three months ended September 30, 2025, compared to $673 thousand in 2024[220]. - Research and development expenses for the nine months ended September 30, 2025, increased by approximately 209% to $1,723 thousand from $557 thousand in 2024[229]. - Selling and marketing expenses for the nine months ended September 30, 2025, rose by approximately 245% to $1,878 thousand compared to $545 thousand in 2024[232]. - General and administrative expenses for the nine months ended September 30, 2025, were approximately $4,997 thousand, an increase of 114% from $2,335 thousand in 2024[234]. Cash Flow and Financing - As of September 30, 2025, the company reported a cash balance of approximately $6,980 thousand after incurring approximately $6,696 thousand in cash used in operating activities[240]. - As of September 30, 2025, the company had cash and cash equivalents of approximately $6,980 thousand, a significant increase from approximately $752 thousand as of December 31, 2024[246]. - Cash used in operating activities for the nine months ended September 30, 2025, was approximately $6,696 thousand, compared to approximately $1,968 thousand for the same period in 2024[247]. - Cash provided by financing activities during the nine months ended September 30, 2025, was approximately $12.8 million, primarily from net proceeds of $17.1 million from the issuance of common stock, preferred stock, and warrants[248]. Compliance and Regulatory Matters - The company received a compliance extension from Nasdaq to demonstrate adherence to the minimum bid price and equity requirements by March 31, 2025[189]. - On April 9, 2025, the company demonstrated compliance with Nasdaq's bid price and equity requirements, avoiding delisting[190]. - The company is subject to a one-year mandatory panel monitor following compliance with Nasdaq requirements[191]. - The company has identified inaccuracies in its 510(k) application for the PainShield MD Plus product and intends to halt future sales of the product[251]. - The company is subject to risks common in the biopharmaceutical industry, including regulatory approvals and competition from new products[252]. Capital Requirements and Future Outlook - The company's future capital requirements will depend on the successful commercialization of its products and the development of future product offerings[249]. - The company anticipates that future operating results will be subject to quarterly variations based on various factors, including distributor ordering patterns and regulatory approvals[250]. Asset Changes - Major changes in assets are primarily attributable to a merger, reflecting the revaluation and consolidation of assets[244]. - Cash provided in investing activities was approximately $111 thousand for the nine months ended September 30, 2025, mainly from cash acquired in the merger[247]. - The company has no off-balance sheet transactions or obligations that may materially affect its financial condition as of September 30, 2025[243]. Stock and Offerings - In September 2025, the company conducted a registered direct offering, issuing 74,114 shares of common stock and prefunded warrants for a total net proceeds of approximately $1.88 million[181]. - The Series H Initial Closing on July 22, 2025, generated gross proceeds of $8 million from the sale of 8,889 shares of Series H Convertible Preferred Stock[185]. - The Series H Purchase Agreement allows for the potential issuance of up to $44 million in additional Series H Preferred Stock over a 36-month period[184]. - The company executed a 1-for-10 reverse stock split effective August 11, 2025, to comply with Nasdaq listing requirements[182].